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Clinical research is vital to clinical care. These days, more
research is conducted by clinicians in more organizations and
across many disciplines.  Thus, at some point in a career, a
clinician will undoubtedly work with researchers or may hold
dual roles as both clinician and research investigator.  While
this can create enormous opportunities for advances in
healthcare, often this can potentially allow for ethical concerns
to surface. These ethical concerns may stem from a limited
understanding of how clinical research differs from clinical care.
Additionally, roles and obligations of a clinician versus clinician-
researcher may unintentionally blur in research settings.
Clarifying these differences for the clinician-researcher as well
as for the patient may help to reduce ethical concerns when
conducting research.
So, what are the differences? In clinical care, the primary goal
is to promote the well-being of the individual patient. That is,
treatment and assessment is tailored to the individual. Ethically,
the potential benefits of therapeutic care prescribed to the patient
must outweigh the risks posed to them.  On the other hand,
the goals of clinical research are to produce generalizable
scientific knowledge that will improve clinical care for future
patients and for society. Thus, in clinical research an individual
patient receives treatment based on the scientific design of a
research protocol and not on individualized care. The care is
standardized and may not be the most optimal care that a
patient could receive. In fact, nontherapeutic procedures that
are part of a study protocol, may pose some risk to patients
without providing individual benefits. However, federal regulations
allow institutional review boards to only approve clinical research
that minimizes risks, maximizes potential benefits, and presents
the value of advanced knowledge for society that outweighs the
risks.
These separate goals suggest distinct roles for the clinician
and clinical-researcher.  Clinician-researchers duties are
protective, not fiduciary. Clinician-researchers are obligated to
protect patient-participants from harm and exploitation in the
course of conducting research. They must protect patient-
participants from facing unnecessary risks to answering the
research question and protect them from any exploitation of
any vulnerabilities due to health, age, income, or other factors.
Further, clinician-researchers must protect the autonomy of
patient-participants by providing accurate and easy to
understand information about the research aims, procedures,
risks and benefits, and treatment alternatives.
Ethical concerns surface when the clinician-researcher believes
he or she should fulfill a therapeutic obligation to the patient-
participant, thereby changing their role and relationship with
the patient-participant. For example, they may not recruit
particular patients due to a belief that the individual will not
benefit from the research, or they may change an aspect of the
research protocol (e.g. reduce the number of assessment follow-
ups) to benefit an individual patient. Although it can be argued
that these behaviors were done for the patient-participant’s
best interests, they still violate research ethics. Emanuel and
colleagues (2000) offer an in-depth discussion of the
requirements that are necessary and sufficient to make clinical
research ethical.  These requirements are the following: value,
scientific validity, fair subject selection, favorable risk-benefit
ratio, independent review, informed consent, and respect for
enrolled subjects.
Unfortunately, when clinician-researchers continue to blur their
role as clinician and clinician-researcher, the research
participant is also affected. Often patients believe that their
clinician will always act with their best interests in mind. They
may fail to comprehend that the purpose of research is not to
promote their individual welfare. This tendency to view research
as a form of medical care contributes to the therapeutic
misconception (Appelbaum, 2002). Tendencies for clinician-
researchers to single out any patient-participant further
contributes to the therapeutic misconception, which ultimately
threatens informed consent and risks exploitation. Thus,
clinician-researchers have an obligation to be honest with
patient-participants about the risks of research that do not
promote the patient-participant’s welfare.  Altogether, an
understanding of research ethics includes knowledge that the
duties of the clinician and clinician-researcher intersect, but
clearly are not identical.
References
Appelbaum, P.S. (2002). Clarifying the ethics of clinical research: A
path toward avoiding the therapeutic misconception. The American
Journal of Bioethics, 2(2), 22-23.
Emanuel, E.J., Wendler, D., & Grady, C. (2000). What makes clinical
research ethical? JAMA, 283, 2701-2711
Distinguishing the Ethics of Clinical Research and Clinical Care
Submitted by Rashelle B. Hayes, PhD
RIPA Ethics Committee
State and Federal Advocacy Issues
The Legislative Committee is busy preparing for the upcoming legislative season.
Here is what we are working on:
Our State Licensing Law: We have just completed the Department of Health
Hearings on the revised regulations from the 2008 licensing revision. They will soon
be implemented. We are now preparing a new licensing update to address some
current issues: The current draft seeks to:
1. Allow the Board of Psychology to investigate and engage in disciplinary action
anyone practicing psychology whether or not identified as a psychologist.
2. Add language to the discipline section that will enable psychologists to be assisted
by a colleague assistance program approved by the Board. The language would
allow the Board to refer a person who is the subject of a disciplinary complaint to the
program for assessment and treatment. The Board would be able to enter into an
agreement with a psychologist to participate in the program without having to come
to a disciplinary finding. The Board would be able dismiss or suspend a complaint if
the psychologist complies and completes the program successfully. The Board would
be able to reinstate the complaint if the psychologist was not compliant with the
agreement.
3. Clarify the Temporary Permit section to allow post-docs to get permits before
they take the EPPP (so they will have completed all requirements but the EPPP and
the second year of supervision) and allow people in post-doctoral programs with
temporary permits to use the title “psychology resident.”
When the bill is passed we will again update the regulations to be in compliance
with the law. We hope the staffing situation at the Department of Health will enable
us to do this promptly this time. In the regulations update we will also seek to clarify
the requirements for supervision and training experiences.
Mandated Insurance Benefits for Autistic Spectrum Disorders: At the request
of the psychologists at the Developmental Disabilities Services at Bradley Hospital,
we are working with them on a bill that would mandate home based treatment services
for kids with pervasive developmental disabilities from private insurance companies.
Our consensus is that we are supportive of the basic intent of the bill. However, there
is one aspect of the bill that we find inappropriate. The bill has been provided to the
sponsor by a national advocacy group, Autism Speaks. The current version would
require the individual responsible for providing the service and supervising home
workers to have a Certificate in Applied Behavioral Analysis. In our view this is
inappropriate. By statute Rhode Island requires the provision of clinical services to
be provided by a healthcare professional licensed by the Department of Health
within their scope of practice, not through a certificate provided by an independent
entity outside the scope of our licensing law. We hope we can resolve this issue
with the sponsor.
Marriage Equality: The RIPA Board has reaffirmed support of Marriage Equality.
RIPA will continue to advocate in support of the bill. Past-President James Campbell
will lead our advocacy for this bill.
Reimbursement Rates: We continue to be concerned that despite the
implementation of federal mental health parity, that some health insurance companies
continue to discriminate against behavioral health patients and professionals by
reimbursing for behavioral health services on a different basis than they reimburse
for medical services. That usually translates to lower levels of reimbursement for
behavioral health care professionals than for medical professionals. This
discrimination impairs accessibility and quality of care. We will continue to submit
our bill that would add “rate parity” to our state mental health benefits law. We seek
to continue to remove the barriers and stigma that behavioral health clients face.
Got a question about ethics in your
professional work, whether clinical or research?
Contact the RIPA Ethics Committee for
assistance from a committee
of your fellow psychologists.
Contact Jack Hutson at 732-2900 or
jhutson@ripsych.org to find the
Ethics on-call member.Submitted by Peter Oppenheimer, Ph.D.
APA Council Representative
